![Bob Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Jackson
Directeur/Membre du Conseil chez
Vescor LLC
Profil
Robert Bowers Jackson is currently a Director at Vescor LLC and Civetta Therapeutics LLC.
He was previously a Director at Dracen Pharmaceuticals, Inc. and a Healthcare Analyst at Janus Henderson Investors US LLC.
He served as an Independent Director at Nuvalent, Inc. from 2017 to 2022.
Dr. Jackson received his undergraduate degree from Rollins College (Florida), his doctorate from West Virginia University, and his MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Bob Jackson
| Sociétés | Poste | Début |
|---|---|---|
Vescor LLC
 Vescor LLC Pharmaceuticals: MajorHealth Technology Discovers and develops autophagy targeted therapeutics for cancer treatment | Directeur/Membre du Conseil | - |
Civetta Therapeutics LLC
 Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancers and other diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Bob Jackson
| Sociétés | Poste | Fin |
|---|---|---|
| NUVALENT, INC. | Directeur/Membre du Conseil | 16/06/2022 |
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Analyst-Equity | 01/01/2001 |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Bob Jackson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Janus Henderson Investors US LLC
Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Finance |
Rollins College (Florida)
 Rollins College (Florida) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
 West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vescor LLC
Vescor LLC Pharmaceuticals: MajorHealth Technology Discovers and develops autophagy targeted therapeutics for cancer treatment | Health Technology |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Civetta Therapeutics LLC
Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for cancers and other diseases | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
